Bausch Health Companies Inc. Payments for (Proceeds from) Businesses and Interest in Affiliates
Bausch Health Companies Inc. (BHC) reported Payments for (Proceeds from) Businesses and Interest in Affiliates of $180.00 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates · last filed 2019-11-04
- Bausch Health Companies Inc. payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2019-09-30 was $0.00.
- Bausch Health Companies Inc. payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2019-06-30 was $0.00.
- Bausch Health Companies Inc. payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2019-03-31 was $180.00M.
- Bausch Health Companies Inc. payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2018-12-31 was $0.00.
- Bausch Health Companies Inc. payments for (proceeds from) businesses and interest in affiliates for fiscal 2018 was -$5.00M.
- Bausch Health Companies Inc. payments for (proceeds from) businesses and interest in affiliates for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Bausch Health Companies Inc. payments for (proceeds from) businesses and interest in affiliates for fiscal 2016 was $19.00M.
| Period end | Payments for (Proceeds from) Businesses and Interest in Affiliates 3 month | Payments for (Proceeds from) Businesses and Interest in Affiliates 6 month | Payments for (Proceeds from) Businesses and Interest in Affiliates 9 month | Payments for (Proceeds from) Businesses and Interest in Affiliates 12 month |
|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $180.00M 10-Q · filed 2019-11-04 | $180.00M derived: sum of 4 quarters · filed 2019-11-04 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $180.00M 10-Q · filed 2019-08-06 | $180.00M derived: sum of 3 quarters · filed 2019-08-06 | $180.00M derived: sum of 4 quarters · filed 2019-11-04 |
| 2019-03-31 | $180.00M 10-Q · filed 2019-05-06 | $180.00M derived: sum of 2 quarters · filed 2019-05-06 | $180.00M derived: sum of 3 quarters · filed 2019-11-04 | $180.00M derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 derived: sum of 3 quarters · filed 2019-11-04 | -$5.00M 10-K · filed 2019-02-20 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | -$5.00M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$5.00M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | -$5.00M 10-Q · filed 2019-05-06 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-02-20 | |||
| 2016-12-31 | $19.00M 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |